Premium
Interactions Between the Hypothalamo‐Pituitary Adrenal Axis and the Thymus in the Rat: A Role for Corticotrophin in the Control of Thymulin Release
Author(s) -
Buckingham J. C.,
Safieh B.,
Singh S.,
Arduino L. A.,
Cover P. O.,
Kendall M. D.
Publication year - 1992
Publication title -
journal of neuroendocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.062
H-Index - 116
eISSN - 1365-2826
pISSN - 0953-8194
DOI - 10.1111/j.1365-2826.1992.tb00171.x
Subject(s) - medicine , endocrinology , corticosterone , dexamethasone , hormone , in vivo , chemistry , in vitro , secretion , peptide hormone , endogeny , biology , biochemistry , microbiology and biotechnology
Our recent observations in man suggested that the secretion of the thymic peptide, thymulin, is influenced by hormones of the pituitary‐adrenal axis. In the present study, we have used the rat as a model in order to examine 1) the effects of corticotrophin (ACTH) and glucocorticoids on the release of thymulin in vivo and in vitro, and 2) the influence of an acute rise in plasma thymulin on the secretion of corticosterone and luteinizing hormone. Immunoreactive thymulin was readily detectable in plasma from male Sprague‐Dawley rats(≃200 g). Chronic bilateral adrenalec‐tomy, which effectively removed endogenous corticosterone, produced highly significant (P<0.01) increases in the plasma concentrations of both ACTH and thymulin. Treatment of the adrenalectomized rats with dexamethasone, in a dose sufficient to suppress the hypersecretion of ACTH, maintained the plasma thymulin at a low level which did not differ significantly (P > 0.2) from that in sham‐operated controls. In vitro, two non‐specific depolarizing agents, K + (56 mM) and veratridine (10 ≃M), caused significant (P<0.01) Ca 2+ ‐dependent increases in thymulin release from segments of rat thymic tissue. Their effects were mimicked by ACTH 1–39 . The secretory responses to ACTH (0.025 to 1 ng/ml) were concentration‐dependent but a very high concentration (2 ng/ml) of the peptide was without effect. Dexamethasone (0.1 μM) reduced (P<0.05) the spontaneous release of thymulin in vitro but potentiated markedly (P<0.01) the secretory responses to ACTH (0.5 to 1.0 ng/ml). Administration of thymulin (0.1 and 10 μg/kg ip) produced, within 10 min, striking increases in the plasma thymulin concentration which were still evident at 30 min. The peptide concentration then declined rapidly and, within 24 h, was lower than that in the corresponding vehicle‐treated controls. The serum concentrations of corticosterone and luteinizing hormone were unaffected by the thymulin treatment. The saline vehicle (2.0 ml/kg ip) also produced a small increase in plasma thymulin concentration which was maximal at 10 min; a further small rise was evident 6 h after the injection but thereafter the thymulin values were indistinguishable from those in uninjected controls. A similar biphasic profile of serum corticosterone was apparent after the saline injection but the serum luteinizing hormone was unaffected. The results suggest that ACTH is a physiological enhancer of thymulin release and that, in certain circumstances, its effects may be potentiated by glucocorticoids.